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Abstract. Rapid diagnostic tests are needed for typhoid fever (TF) diagnosis in febrile children in endemic areas.
Five hundred children admitted to the hospital in Cambodia between 2009 and 2010 with documented fever (³ 38°C)
were investigated using blood cultures (BCs), Salmonella Typhi/Paratyphi A real-time polymerase chain reactions
(PCRs), and a Typhoid immunoglobulin M flow assay (IgMFA). Test performance was determined by conventional
methods and Bayesian latent class modeling. There were 32 cases of TF (10 BC- and PCR-positive cases, 14 BC-positive
and PCR-negative cases, and 8 BC-negative and PCR-positive cases). IgMFA sensitivity was 59.4% (95% confidence
interval = 41–76), and specificity was 97.8% (95% confidence interval = 96–99). The model estimate sensitivity for BC
was 81.0% (95% credible interval = 54–99). The model estimate sensitivity for PCR was 37.8% (95% credible interval =
26–55), with a specificity of 98.2% (95% credible interval = 97–99). The model estimate sensitivity for IgMFA (³ 2+) was
77.9% (95% credible interval = 58–90), with a specificity of 97.5% (95% credible interval = 95–100). The model estimates
of IgMFA sensitivity and specificity were comparable with BCs and better than estimates using conventional analysis.
INTRODUCTION
Salmonella enterica serotype Typhi (S. Typhi) is the main
causative organism of typhoid fever, although S. enterica
Paratyphi A is becoming increasingly common in some areas,
including north India, Nepal, and China.1 An estimated 21 mil-
lion new cases of typhoid occur each year, resulting in approx-
imately 216,000 deaths.2 The diagnosis of typhoid fever is
challenging, because the clinical presentation can be confused
with other infectious diseases, such as dengue, malaria, rick-
ettsial infections, leptospirosis, and melioidosis; a secure diag-
nosis requires laboratory confirmation.3
Blood culture is the recommended diagnostic method, but
it is reported to be positive in only 40–80% of cases.4 The
sensitivity of blood culture varies according to the stage of
illness, the volume of blood inoculated into the culture, and
prior antimicrobial treatment.5 A low number of bacteria cir-
culating in the blood is a crucial limitation.6 Culture of bone
marrow is more sensitive than blood but not feasible in rou-
tine practice.7 S. Typhi and S. Paratyphi A DNA can be suc-
cessfully detected in blood by nucleic acid amplification, but
like with culture, sensitivity is limited by the low number of
circulating organisms.8 Furthermore, few laboratories in endemic
resource-limited countries have the capacity for bacterial cul-
ture or polymerase chain reaction (PCR). The Widal test is
simple to perform and still widely used but limited by false-
positive and -negative results.4 Enzyme-linked immunosorbent
assays (ELISAs) and a number of rapid serological diagnostic
tests have been evaluated with variable results.9–11
The Typhoid F immunoglobulin M flow assay (IgMFA) is a
typhoid-specific rapid diagnostic test for use on human serum
or whole-blood samples, which was developed by the Royal
Tropical Institute (KIT) in Amsterdam, that detects S. Typhi
lipopolysaccharide (LPS) -specific IgM antibodies using a
one-step immunochromatographic lateral flow assay.12,13 Eval-
uations in Indonesia have suggested a sensitivity of 59% com-
pared with blood culture, with a range from 41% to 90%,
depending on the stage of illness, and a specificity of 98%
based on results obtained for patients with clinical suspicion
of typhoid fever when typhoid fever was later excluded.13
Recent studies have drawn attention to the importance of
antimicrobial-resistant typhoid fever in Cambodia in South-
east Asia.14–17 At Angkor Hospital for Children (AHC), a pedi-
atric hospital in Siem Reap in northwest Cambodia, S. Typhi
is the most common isolate from the blood culture. Despite a
capacity for blood culture confirmation at this hospital, many
children with a negative blood culture are clinically diagnosed
with typhoid fever. Alternative simple rapid diagnostic tests
for typhoid are needed in such locations. Here, we have esti-
mated the diagnostic accuracy of the KIT IgMFA test for the
diagnosis of typhoid fever compared with blood culture, a
real-time PCR assay, and clinical assessment in a group of
children admitted to hospital with fever. Blood culture is an
imperfect gold standard against which to compare new point
of care tests; therefore, we have used a Bayesian latent class
modeling approach to measure the sensitivity and specificity
of all of the tests used.18–20
MATERIALS ANDMETHODS
Study site. AHC is a charitably funded hospital and one
of two pediatric hospitals in the town of Siem Reap. It
provides free medical care to children ages 0–15 years from
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the town, province, and surrounding provinces. The hospi-
tal has approximately 125,000 attendees and 4,000 admis-
sions per year.
Patients. Children consecutively admitted to AHC with a
documented fever of ³ 38°C within 48 hours of admission who
were < 16 years of age were eligible for entry to the study.
There were two periods of prospective study recruitment. The
first period was between April and May of 2009 (N = 125),
and it was the subject of a previous report.12 The second
period of recruitment was between March and August of
2010 (N = 375), and it was part of a larger 1-year study of the
causes of fever among children admitted to this hospital that
is reported elsewhere.16 The two periods of recruitment were
chosen to be during the season in which typhoid fever is most
common in Cambodia. Blood was collected from the patients
on admission and discharge where possible. Five hundred
children were included in this study of typhoid rapid diagnos-
tic tests if sufficient admission whole-blood and serum blood
samples were available for analysis.
Ethical approval for the study was granted by the AHC
Institutional Review Board, the Oxford Tropical Research
Ethics Committee (Oxtrec 53-09), and the Research Ethics
Committee of the Liverpool School of Tropical Medicine.
Informed written or thumbprint consent was taken from the
subjects’ parents or caretakers.
Clinical procedures. Demographic and clinical information
was recorded on a study case report form at the time of
admission. Blood was collected at the time of admission for
complete blood count and blood culture; ethylenedinitrilo
tetraacetic acid (EDTA) whole blood was collected for PCR,
and serum was collected for the IgMFA. The serum samples
were frozen at −80°C and tested later. A diagnosis or differ-
ential diagnosis was proposed and recorded by the junior
clinician responsible for admitting the child. At the time of
discharge, a judgment was made based on the blood culture
results and assessment by an experienced pediatrician as to
whether the clinical features, laboratory results, and inpatient
progress of the patient were consistent with typhoid fever.
These features included some (but not necessarily all) of the
following features: a febrile illness of > 3 days duration, the
presence of abdominal symptoms (abdominal pain, diarrhea,
or constipation), a documented fever of ³ 39°C, hepatomeg-
aly and/or splenomegaly, a low or normal white cell count,
elevation of liver enzymes (serum glutamic oxaloacetic trans-
aminase [SGOT] and serum glutamic pyruvic transaminase
[SGPT]) two to three times above the normal range, a slow
defervescence with ceftriaxone treatment (the standard antibi-
otic used for hospital-admitted febrile children), and no alter-
native confirmed diagnosis established.
Blood culture. A volume of 1–2 mL blood, dependent on
age, was inoculated into 20 mL tryptic soy broth with sodium
polyanethole sulfonate (SPS). All blood bottles were exam-
ined daily and subcultured at 24 hours, 48 hours, and 7 days
after incubation or if turbid, on examination.16 Subcultures
were onto 5% sheep blood agar and chocolate agar incubated
in a candle jar and MacConkey agar incubated in air for
48 hours (all media; Oxoid, Basingstoke, United Kingdom;
blood bottles, stoppers and caps supplied by PN Laboratories,
Bangkok, Thailand). Bacterial isolates were identified by
standard methods, including biochemical test using API test
strips (bioMe´rieux, Marcy l’Etoile, France) and agglutina-
tion with specific antisera (Biorad, Hertfordshire, United
Kingdom). All media and tests are subject to regular inter-
nal quality assessment.
Real-time PCR. DNA extraction was performed from
whole blood stored in EDTA using a QIAmp DNA Mini Kit
(Qiagen, United Kingdom). The real-time PCR method
previously published by Nga and others8 was followed using
25-mL reactions containing 5 mL extracted DNA for the detec-
tion of S. Typhi and S. Paratyphi A.
IgMFA. The IgMFA was tested on 500 admission serum
samples according to the manufacturer’s instructions. For the
first 125 children, the tests were performed at the time of
admission. For the remaining 375 children, the tests were not
performed at the time of admission but 1 year later; the tests
were on serum samples taken on admission that had been
stored at −80°C. In all cases, the testers were blind to the
clinical details and laboratory results. The result for each
sample was graded as recommended using the band intensity
from 0 to 4+.21 For the first 125 samples, the test was
performed and read by a single observer. For the remaining
samples, each test was performed by one scientist, and the
results were read, after a short period of training, indepen-
dently by three technicians blinded to study number. The
assay card was relabeled, and each card was read again inde-
pendently by the same three blinded technicians. Cards were
read within 30 minutes of preparation. For each case, the
average of all readings was taken as the final result.
Analysis. Analysis was performed using Stata version 10.0
(College Station, TX). The k-statistic22 was used to measure
interrater and intrarater agreement of the IgMFA-positive
band intensity in 375 assays. The k-statistic ranges between
zero and one, with one representing perfect agreement and
zero representing no more agreement than would be expected
to occur on the basis of chance alone. By convention, k-values
of £ 0.20 are considered to reflect poor agreement, k-values
from > 0.20 to £ 0.40 are considered to reflect fair agreement,
k-values from > 0.40 to £ 0.60 are considered to reflect mod-
erate agreement, k-values from < 0.60 to £ 0.80 are considered
to reflect good agreement, and k-values of > 0.80 are consid-
ered to reflect very good agreement. Sensitivity, specificity,
and predictive values with 95% confidence intervals were
calculated using laboratory-confirmed tests (blood culture- and/
or PCR-positive) and all cases (blood culture- and/or PCR-
positive and/or clinical diagnosis of typhoid fever) as compar-
ators. The Standards for Reporting of Diagnostic Accuracy
(STARD) reporting guidelines were followed.23 The Bayesian
latent class model (LCM) as described by Dendukuri and
Joseph24 was used to approximate the prevalence, sensitivi-
ties, and specificities of all tests.18 The Bayesian LCM does
not assume that any test is perfect but considers that each test
could be imperfect in diagnosing the true disease status. The
true disease status of the patient population is then defined on
the basis of overall prevalence (the probability that a patient
with suspected typhoid fever is truly infected with S. Typhi).
LCMs estimate the prevalence and accuracy of each test
based on the observed frequency of the possible combina-
tions of test results. To estimate the accuracy of different
diagnostic tests, the model that we used assumed (1) some
correlation between the blood culture and PCR results, (2)
that blood culture specificity was fixed at 100%, and (3) that
there was a random effect variable representing different
amounts of bacteria in each infected subject. The model
assumed that no other prior information (non-informative
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priors) about the unknown parameters (prevalence, sensitiv-
ities, and specificities) was available. The median values of
all the parameters were reported together with the 95%
credible intervals.25 The Bayesian LCM was run using
WinBUGS 1.4 (Medical Research Council and Imperial Col-
lege London, United Kingdom).
RESULTS
Patients. In total, 500 children with fever were studied. The
median (interquartile range; range) age of the children was
2.7 years (1.1–8.0 years; 1 month to 15 years), and 264 (53%)
children were male. The median (interquartile range; range)
duration of illness before hospital admission, which was reported
for 489 (98%) patients, was 3 days (2–6 days; 0–30 days). Chil-
dren were not systematically tested for human immunodefi-
ciency virus (HIV), although 20 (4%) children were known to
be positive; 9 of 398 children tested had microscopy-positive
malaria: 2 children with Plasmodium falciparum, 3 children
with P. vivax, and 4 children with mixed P. falciparum and
P. vivax. There were 19 (3.8%) in-hospital deaths, none of
which were attributed to typhoid fever.
Typhoid fever was considered in the differential diagnosis
by the admitting clinician in 80 (16.0%) children (Figure 1).
At the time of discharge, 25 (31.3%) of these children were
diagnosed with typhoid fever. Typhoid was not suspected
at the time of admission in 420 (84.0%) children, and in
19 (4.5%) of these children, the final diagnosis was considered
to be typhoid. In total, 44 (8.8%) children were diagnosed
with typhoid fever: 24 (54.5%) cases were confirmed by blood
culture, including 10 cases that were also positive by PCR,
8 (18.2%) cases were confirmed with a negative blood culture
but positive PCR, and 12 (25.0%) cases were confirmed with
negative blood culture and PCR as well as based on clinical
assessment, laboratory results, and in-patient progress. Com-
mon diagnoses in the remaining 456 patients without typhoid
included lower respiratory tract infection (154), diarrhea or
dysentery (82), dengue (38), upper respiratory tract infection
(27), and central nervous system infection (22); 15 patients
had a significant positive blood culture containing Streptococcus
pneumoniae (5), Escherichia coli (3), Haemophilus influenzae
(2), Acinetobacter baumanii (1), Burkholderia cepacia (1), B.
pseudomallei (1), Pseudomonas aeruginosa (1), or Staphylococ-
cus aureus (1). An unidentified Gram-negative bacillus was
isolated in five other cases, which was inconsistent with the clin-
ical picture and thought to be an environmental contaminant.
The clinical and laboratory features of each group of
patients are shown in Table 1. Previous consumption of an
antimicrobial was documented in 112 (22.4%) patients, includ-
ing an antimicrobial potentially active against S. Typhi in 83
(16.6%) patients. In another 156 (31.2%) cases, the medica-
tion given was unknown. The median (interquartile range;
range) volume of blood taken for culture for all the children
was 2.0 mL (1.6–2.5 mL; 0.1–13.2 mL). In the blood culture-
positive group, the median (interquartile range) volume was
2.0 mL (1.83–2.3 mL) compared with 1.9 mL (1.6–2.8 mL) in the
blood culture-negative group (P = 0.791; Mann–WhiteyU test).
IgMFA results. In total, 106 patients had a positive IgMFA
test. In 72 patients, the reading was 1+. In 10 patients, it was 2+.
In 14 patients, it was 3+, and in 10 patients, it was 4+. For 375
cases in which three separate raters scored the result, the k-
statistic for the interobserver variability for all IgMFA results
was 0.84 (range = 0.56–0.92), suggesting very good agreement.
The intraobserver variability for all IgMFA results for the
three raters was 0.86, 0.83, and 0.87, also suggesting very good
agreement. For scoring the result positive or negative based on
a cutoff of ³ 2+, the interobserver k-statistic was 0.92, and the
intraobserver k-values were 0.90, 0.90, and 0.89.
The sensitivity, specificity, and positive and negative pre-
dictive values of the different intensities of the IgMFA result
are shown in Table 2. The values were calculated for children
with a laboratory-confirmed diagnosis of typhoid as well as
those children with a laboratory and/or clinical diagnosis com-
pared with the children without a diagnosis of typhoid. For
Figure 1. Flowchart showing enrolment of 500 children admitted to the study. BC = blood culture; pos = positive.
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both comparisons, the IgMFA sensitivity gradually decreased
as increasing cutoff intensities were used. There was stepwise
increase in specificity between the reading of ³ 1+ at 83% and
³ 2+ at 98%.
The IgMFA was positive at ³ 2+ in 10 children who were
considered not to have typhoid. Two children, one with juve-
nile idiopathic arthritis and one with acute glomerulonephri-
tis, may potentially have had cross-reactive antibodies. The
others were diagnosed with pneumonia (four), dysentery (two),
bowel obstruction (one), and dental abscess (one).
Evaluation using a Bayesian LCM. We applied LCMs to
explore the sensitivity and specificity of blood culture, real-
time PCR, and IgMFA in typhoid fever. Sensitivities of each
possible cutoff for the intensity of IgMFA reading (³ 1+, ³ 2+,
³ 3+, and 4+) were assessed from the model. The specificity of
blood culture was assumed to be 100%, and the blood culture
and PCR were assumed to be correlated. The sensitivity of
blood culture was 81.0% (95% credible interval = 54–99)
(Table 3). The sensitivity of the real-time PCR was 37.8%,
with a specificity of 98.2%. The IgMFA sensitivity ranged
Table 1
Demographic, clinical, and laboratory features of studied children
BC- and
PCR-positive
BC-positive and
PCR-negative
BC-negative and
PCR-positive
BC- and PCR-negative
(clinical typhoid)
BC- and PCR-negative
(not typhoid)
Number 10 14 8 12 456
Age (years) 5.8 (3.3–12.5) 9.3 (4.6–12.9) 0.9 (0.7–2.7) 8.1 (4.8–11.2) 2.4 (1.0–7.5)
Sex (male) 5 (50) 5 (36) 4 (50) 8 (68) 242 (53)
Duration of illness 5.0 (5.0–7.0) 6.0 (4.0–10.0) 2.0 (2.0–3.0) 6.5 (3.5–10.0) 3.0 (2.0–5.0)
Previous antibiotics 7 (70) 6 (43) 2 (25) 5 (42) 69 (15)
Headache 5 (50) 8 (57) 0 (0) 8 (67) 94 (21)
Abdominal pain 8 (80) 9 (64) 1 (13) 9 (75) 111 (24)
Diarrhea 2 (20) 5 (36) 7 (88) 5 (42) 154 (32)
Constipation 2 (20) 1 (7) 0 (0) 1 (8) 24 (5)
Vomiting 5 (50) 8 (57) 4 (50) 6 (50) 210 (46)
Cough 1 (10) 4 (29) 7 (88) 4 (33) 245 (54)
Shortness of breath 0 (0) 3 (21) 2 (25) 0 (0) 191 (42)
Rigors 3 (30) 5 (36) 0 (0) 3 (25) 28 (6)
Temperature ³ 39 °C 6 (60) 6 (43) 1 (13) 5 (42) 133 (29)
Jaundice 0 (0) 0 (0) 1 (13) 1 (8) 14 (3)
Hepatomegaly 6 (60) 5 (36) 1 (13) 2 (17) 117 (26)
Splenomegaly 1 (10) 1 (7) 0 (0) 0 (0) 22 (5)
Altered consciousness 0 (0) 2 (14) 0 (0) 0 (0) 61 (13)
Hemoglobin (g/dL) 8.0 (6.6–9.3) 9.5 (7.3–10.3) 10.1 (9.0–11.9) 8.8 (7.1–11.0) 9.9 (8.6–11.2)
White cell count ( +109/L) 4.4 (4.0–7.0) 6.0 (5.1–9.7) 10.7 (9.6–14.4) 8.6 (6.3–11.2) 12.4 (7.7–17.5)
Neutrophils (%) 3.4 (2.1–4.1) 4.2 (2.9–6.2) 7.1 (4.8–8.8) 5.9 (4.3–6.6) 7.1 (4.3–12.1)
Lymphocytes ( +109/L) 1.9 (1.0–2.6) 1.5 (0.9–2.2) 3.8 (2.7–6) 2.2 (1.1–4.0) 2.8 (1.6–5)
Monocytes ( +109/L)* 0.3 (0.1–0.6) 0.4 (0.3–0.6) 0.7 (0.1–1.1) 0.5 (0.4–0.7) 0.6 (0.3–1.0)
Eosinophils ( +109/L)* 0 0 0 (0–0.2) 0 0
Platelet count ( +106/L) 162 (128–213) 292 (186–328) 356 (300–482.5) 313 (241–486.5) 328 (222–466)
Volume of blood
taken for culture (mL) 2.0 (1.8–2.3) 2.1 (1.9–2.2) 2.1 (1.9–2.9) 1.7 (1.5–2.6) 2.0 (1.6–2.5)
Proportions are expressed as number (%), and continuous variables are expressed as median (interquartile range). BC = blood culture.
*These results were from 491 samples available for analysis.
Table 2
Conventional sensitivity and specificity results for each laboratory method (blood culture, PCR, and IgMFA with differing cutoff values of 1+, 2+,
3+, and 4+) compared with laboratory-confirmed typhoid cases and all typhoid cases (laboratory-confirmed plus clinically suspected cases)
Test
Test positive
in typhoid cases
Test positive in
non-typhoid cases
Sensitivity
(95% credible interval)
Specificity
(95% credible interval)
PPV
(95% credible interval)
NPV
(95% credible interval)
Laboratory-confirmed typhoid
(N = 32) compared with
non-typhoid cases
Blood culture 24/32 0/456 75 (56.6–88.5) 100 (99.2–100) 100 (85.8–100) 98.3 (96.6–99.3)
PCR 18/32 0/456 56 (37.7–73.6) 100 (99.2–100) 100 (81.5–100) 97 (95.1–98.4)
³ IgMFA 1+ 22/32 78/456 68.8 (50.0–83.9) 82.9 (79.1–86.2) 22 (14.3–31.4) 97.4 (95.3–98.8)
³ IgMFA 2+ 19/32 10/456 59.4 (40.6–76.3) 97.8 (96.0–98.9) 65.5 (45.7–82.1) 97.2 (95.2–98.5)
³ IgMFA 3+ 16/32 4/456 50.0 (31.9–68.1) 99.1 (97.8–99.8) 80 (56.3–94.3) 96.6 (94.5–98.0)
³ IgMFA 4+ 8/32 1/456 25.0 (11.5–43.4) 99.8 (98.8–100) 88.9 (51.8–99.7) 95.0 (92.6–96.8)
Laboratory-confirmed
clinically suspected typhoid
(N = 44) compared with
non-typhoid cases
Blood culture 24/44 0/456 54.5 (38.8–69.6) 100 (99.2–100) 100 (85.8–100) 95.8 (93.6–97.4)
PCR 18/44 0/456 40.9 (26.3–56.8) 100 (99.2–100) 100 (81.5–100) 94.6 (92.2–96.4)
³ IgMFA 1+ 28/44 78/456 63.6 (47.8–77.6) 82.9 (79.1–86.2) 26.4 (18.3–35.9) 95.9 (93.5–97.7)
³ IgMFA 2+ 24/44 10/456 54.5 (38.8–69.6) 97.8 (95.9–98.9) 70.6 (52.5–84.9) 95.6 (93.3–97.3)
³ IgMFA 3+ 20/44 4/456 45.5 (30.4–61.2) 99.1 (97.8–99.8) 83.3 (62.6–95.3) 95.0 (92.6–96.7)
³ IgMFA 4+ 9/44 1/456 20.5 (9.8–35.3) 99.8 (98.8–100) 90.0 (55.5–99.7) 92.9 (90.2–95.0)
NPV = negative predictive value; PPV = positive predictive value.
EVALUATION TYPHOID IGM FLOW ASSAY, CAMBODIA 117
with the different cutoff intensities from ³ 1+ (90%; 95%
credible interval = 79–94%) to 4+ (29.6%; 95% credible inter-
val = 22–35%). The reverse was observed for specificity with
the highest at 4+ (99.6%; 95% credible interval = 99–100%)
and lowest at 1+ (82.9%; 95% credible interval = 82–85%).
The calculated prevalence from the model was 6% (95%
credible interval = 4–9%), which is consistent with the preva-
lence of 8.8% based on laboratory-confirmed and clinically
diagnosed cases.
Using the IgMFA cutoff of ³ 2+, the proportion of IgMFA-
positive results for each category of patient is in Figure 1. In
the patients with a clinical suspicion of typhoid at the time of
admission, an IgMFA of ³ 2+ had a positive predictive value
of 16 out of 18 (89%) for laboratory-confirmed and clinically
diagnosed typhoid and a negative predictive value of 85%.
The corresponding values in the patients not thought to have
typhoid on admission were 50% and 95%. The proportion of
positive samples for each test at different duration of illness is
shown in Figure 2.
DISCUSSION
Evaluations of rapid diagnostic tests for typhoid fever have
been hampered by the lack of a suitable gold standard because
of low sensitivity of blood and bone marrow culture.5,26–29 We
have used an S. Typhi and Paratyphi A real-time PCR assay
on blood to increase the number of laboratory-confirmed
cases.8 In addition, we have used a Bayesian LCM to provide
an unbiased statistical approach to this issue without the need
for a gold standard. This approach is being increasingly used
in the evaluation of diagnostic tests for infectious diseases.18,20
This use is the first use of this type of analysis to evaluate
typhoid diagnostic tests.
Using a conventional approach, the sensitivity and specificity
of the typhoid IgMFA compared with laboratory-confirmed
typhoid cases ranged from 25% to 69% and 83% to 99%
respectively. The results were dependent on the intensity of
the band within the IgMFA window (ranging from 1+ to 4+).
The Bayesian LCM model gave generally higher values
for the IgMFA sensitivity at each intensity cutoff but similar
specificities. The results suggest that the IgMFA may be more
sensitive than previously shown.13 A result of ³ 2+ in the
IgMFA seemed to be the optimum cutoff, with a sensitivity
of 77.0% (95% credible interval = 58–90%) and a specificity
of 98% (95% credible interval = 95–100%).
The sensitivity of blood culture in the Bayesian LCM
model was 81.0% (95% credible interval = 54–99%). Previous
published sensitivities, using the combined cultures of blood,
bone marrow, and other samples as a reference standard,
have varied between 40% and 80%.5 The median volume of
blood taken for culture in this study was quite low at 2.0 mL
but reflects the young age of the children studied. These
results suggest that blood culture may be more sensitive than
is generally appreciated. The negative blood culture in the
group with a clinical diagnosis of typhoid cannot be explained
by smaller volumes of blood taken for culture or a history of
taking an antimicrobial potentially active against typhoid.
The real-time PCR sensitivity of 38% (95% credible
interval = 26–55%), which was evaluated in the Bayesian
LCM, was low, although the specificity was high at 98%.
More than one-half of the blood culture patients were PCR-
negative. This counterintuitive result may relate to the differ-
ence in the volumes of blood in the culture (median = 2.0 mL)
compared with smaller volumes used to extract the DNA for
PCR. The children who were blood culture-negative but PCR-
positive represent an interesting group. They were younger
than the other patients with blood culture-confirmed typhoid
(with a median age of 0.9 years [interquartile range = 0.7–
2.7 years]), with a short duration of illness before admission
and clinical features that did not suggest typhoid. They may
represent a previously described group of young children who
have a non-specific illness not recognized as typical typhoid
but with S. Typhi isolated from their blood culture.2,3
The IgMFA test is simple, can be used at the bedside using
whole blood, and requires very little training to perform and
read the results. The test is rapid, with a result available
within 30 minutes, and it contains stabilizing compounds for
use in hot countries. The interrater and intrarater k-values for
reading the intensity of the bands suggested very good agree-
ment, showing that a cutoff of ³ 2+ could be used as a reliable
end point. The use of the IgMFA varied according to the
duration of illness before testing. The test was more sensitive
when the duration of illness was longer (> 5 days), presumably
because of an increasing IgM antibody response, which is
consistent with previous observations.13
The positive predictive value of the IgMFA test was better
in patients in whom there was a clinical suggestion of typhoid
fever at the time of admission, and the negative predictive
value was better in those patients in whom typhoid was not
suspected. Such a test could potentially be used to rule in
typhoid in those patients with clinically suspected disease and
rule it out in those patients in whom typhoid is not suspected.
A clinical diagnostic rule to help standardize the selection of
Table 3
Bayesian model sensitivity and specificity results for the different
IgMFA cutoffs
Model Sensitivity (95% credible interval) Specificity (95% credible interval)
Culture 81.0 (54.1–99.1) 100
PCR 37.8 (25.9–55.1) 98.2 (96.7–99.2)
IgMFA
³ 1+ 90.0 (78.6–93.8) 84.7 (82.9–84.7)
³ 2+ 77.0 (58.2–90.4) 97.5 (95.4–99.5)
³ 3+ 62.5 (51.3–69.2) 99.8 (98.7–99.8)
³ 4+ 29.6 (22.2–34.6) 99.6 (99.6–100)
Figure 2. Duration of illness before admission to hospital in
patients with a positive laboratory test (blood culture-, PCR-, or IgMFA-
positive at two or higher). Each bar denotes the duration of illness
(< 4, 4–7, and > 7 days).
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patients with a higher or lower probability of typhoid could be
helpful if that approach was used, but as of now, a clinical
diagnostic rule has not been developed for children, which
has been proposed for adults.30,31
The study is limited, like in many typhoid diagnostic stud-
ies, by the low number of laboratory-confirmed typhoid cases.
We did not include bone marrow culture as part of our study,
and the lack of a satisfactory gold standard led to the diagno-
sis of clinically suspected cases without laboratory confirma-
tion. The use of Bayesian LCM should help to address this
issue. An additional limitation was that we were unable to test
any cross-reactions from the test in patients with typhoid
fever caused by S. Paratyphi A, because it is a rare cause of
typhoid fever in our setting. There was a limited number of
children with bacteremia caused by other organisms. The only
potential cross-reactivity with other causes of bacteremia
noted for the IgMFA test occurred in two patients who were
blood culture-positive for E. coli and S. pneumoniae. In both
instances, the result was positive at 1+ and would have been
scored negative with a 2+ cutoff. The inclusion of consecutive
febrile children in this endemic setting is a strength of the
study and makes the findings more generalizable.
The IgMFA test with a cutoff of 2+ seems to be a promising
rapid diagnostic test. Larger evaluations in other settings and
a wide range of ages are needed to confirm and extend these
findings. The contribution of real-time PCR to the laboratory
confirmation of typhoid and the value of the Bayesian LCM
in the evaluation of new typhoid diagnostic tests require addi-
tional study.
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